Why Diabetes Stock Insulet Soared 28% in November
Shares of Insulet (NASDAQ: PODD) surged 27.8% in November, according to data from S&P Global Market Intelligence. The S&P 500 returned 3.6% last month.
The Boston-area healthcare company is the leader in tubeless insulin pump technology with its Omnipod pump.
Insulet stock has now pumped out a gain of 129% in 2019 through Dec. 2, compared with the broader market's 26.5% return.
Source Fool.com
